Kowa Pharmaceuticals America Inc., of Montgomery, Ala., a subsidiary of Kowa Co. Ltd., of Nagoya, Japan, said it will co-promote Dublin-based Allergan plc's Bystolic (nebivolol), a beta blocker approved for the treatment of hypertension to lower blood pressure, in the U.S. Under their agreement, Kowa's nationwide sales force will co-promote the drug to cardiologists and select primary care health care providers across the country along with the company's cholesterol-lowering drug Livalo (pitavastatin) tablets.